A dispute over the documentation to the medicine Esbriet shows how much controversy is stirred up by the disclosure of registration documents for medicines to third parties. How to balance the interests of innovative pharmaceutical companies, manufacturers of cheaper generics, and doctors who seek full knowledge of the safety and efficacy of the drugs they prescribe?
In addition to direct public funding for innovative activity, e.g. grants and subsidised loans, tax instruments are also a major element of support for innovation.
The dynamic growth in market share of functional foods calls for a critical review of myths that have arisen around R&D projects in the food sector.
An interview with Prof. Jan Lubiński, geneticist and researcher into the role of microelements in prevention of cancer, founder and CEO of Read-Gene SA, and member of the Council of the National Centre for Research and Development.
In the innovativeness of its economy, Poland ranks 4th from last in the European Union, but greater support is planned for highly innovative projects that show promise for implementation and commercialisation in Poland.